Abstract
Aim
This paper aimed to create a novel and effective surgical pathway and a strategy for breast cancer patients in the Gynecology Department at the University Hospital of Sousse, Tunisia, to decrease unnecessary variation in practice, to assure timely care, and to reduce the waiting times for surgery previously found.
Subject
With the increase in breast cancer incidence and the growing complexity of surgical treatments, ensuring that all patients have access to the appropriate treatment within an appropriate time has become a priority for many countries.
Methods
It was an interventional quasi-experimental study based on assessing professional practices using the process approach method. The study focused on the surgical pathway of women with breast cancer followed and scheduled for surgical treatment.
Results
The sample included 80 women. A total of eight waiting times were calculated. The global time to first treatment (surgical treatment) was 44.5 [30.25–58] days. After the intervention, this waiting time significantly improved, with (p-value < 0.05). The global time of access to surgery was 28 days with an IIQ of [15–34.75], and a significant improvement with the new surgical pathway (p-value < 0.05).
Conclusion
Delays in access to care are a potential marker of inequalities in access to care and an indicator of the health care system's performance. They can influence patients’ prognosis, diagnosis, and treatment. The pathway and strategy advanced in the present paper will be used as a model to be applied in other cancer centers to reduce delays.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Althuis MD, Dozier JM, Anderson WF, Devesa S, Brinton LA (2005) Global trends in breast cancer incidence and mortality 1973–1997. Int J Epidemiol 34:405–412. https://doi.org/10.1093/ije/dyh414
Anders CK, Johnson R, Litton J, Phillips MB (2009) Breast Cancer before Age 40 Years. Sem Oncol 36:237–249. https://doi.org/10.1053/j.seminoncol.2009.03.001
Arndt V, Stürmer T, Stegmaier C, Ziegler H, Becker A, Brenner H (2003) Provider Delay among Patients with Breast Cancer in Germany: A Population-Based Study. JCO 21:1440–1446. https://doi.org/10.1200/JCO.2003.08.071
Bairati I, Jobin E, Fillion L, Larochelle M, Vincent L (2007) Determinants of delay for breast cancer diagnosis. Cancer Detect Prev 31:323–331. https://doi.org/10.1016/j.cdp.2007.08.001
Bannour I, Briki R, Zrairi F, Zahmoul T, Hamchi H, Kammoun Belajouza S, Hidar S, Ben Fatma L, Boughizane S, Mokni M (2018) Breast cancer in the Maghreb: epidemiology and control strategies. Review. Tunis Med 96:658–664
Ben Abdallah M, Zehani S, Maalej M (2009) Breast Cancer in Tunisia: Epidemiological Characteristics and Evolutive Trend of the Incidence. Tunis Med 87(n°07):417–425
Ben Ahmed S, Aloulou S, Bibi M, Landolsi A, Nouira M, Ben Fatma L, Kallel L, Gharbi O, Korbi S, Khaïri H, Kraïem C (2002) Breast cancer prognosis in Tunisian women: analysis of a hospital series of 729 patients. Sante Publique 14:231–241
Bleicher RJ, Ruth K, Sigurdson ER, Ross E, Wong YN, Patel SA, Boraas M, Topham NS, Egleston BL (2012) Preoperative Delays in the US Medicare Population With Breast Cancer. JCO 30:4485–4492. https://doi.org/10.1200/JCO.2012.41.7972
Boussen H, Bouzaiene H, Ben Hassouna J, Gamoudi A, Benna F, Rahal K (2008) Inflammatory Breast Cancer in Tunisia : Reassessment of Incidence and Clinicopathological Features. Sem Oncol 35:17–24. https://doi.org/10.1053/j.seminoncol.2007.11.017
Bryere J, Tron L, Menvielle G, Launoy G, French Network of Cancer Registries (FRANCIM) (2019) The respective parts of incidence and lethality in socioeconomic differences in cancer mortality. An analysis of the French network Cancer registries (FRANCIM) data. Int J Equity Health 18:189. https://doi.org/10.1186/s12939-019-1087-y
Caplan L (2014) Delay in Breast Cancer : Implications for Stage at Diagnosis and Survival. Fron. Public Health 2. https://doi.org/10.3389/fpubh.2014.00087
Cherif A, Dhaouadi S, Osman M, Hsairi M (2019) Breast Cancer burden in Tunisia : situation in 2017 and projections by 2030. Eur J Public Health 29(ckz186):232. https://doi.org/10.1093/eurpub/ckz186.232
Debarre J, Giraud J (2016) Study of waiting time for colon and prostate cancers in Poitou-Charentes. ORS Poitou-Charentes
Equator Network (n.d.) Better reporting of interventions: template for intervention description and replication (TIDieR)checklist and guide
Evaluation of professional practices in health care institutions : surgery for breast lesions : first-line management (2002)
GLOBOCAN (2020) The Global Cancer Observatory : Guidelines for the management of symptomatic breast disease (2005). Eur J Surg Oncol (EJSO) 31:1–21. https://doi.org/10.1016/j.ejso.2005.02.006
Halsted WS (1907) The results of radical operations for the cure of carcinoma of the breast. Ann Surg 46:1–19. https://doi.org/10.1097/00000658-190707000-00001
Hansen RP, Vedsted P, Sokolowski I, Søndergaard J, Olesen F (2011) Time intervals from first symptom to treatment of cancer : a cohort study of 2,212 newly diagnosed cancer patients. BMC Health Serv Res 11:284. https://doi.org/10.1186/1472-6963-11-284
Ho PJ, Cook AR, Binte Mohamed Ri NK, Liu J, Li J, Hartman M (2020) Impact of delayed treatment in women diagnosed with breast cancer : A population-based study. Cancer Med 9:2435–2444. https://doi.org/10.1002/cam4.2830
Hoffmann TC, Glasziou PP, Boutron I, Milne R, Perera R, Moher D, Altman DG, Barbour V, Macdonald H, Johnston M, Lamb SE, Dixon-Woods M, McCulloch P, Wyatt JC, Chan AW, Michie S (2014) Better reporting of interventions : template for intervention description and replication (TIDieR) checklist and guide. BMJ 348:g1687–g1687. https://doi.org/10.1136/bmj.g1687
Jassem J, Ozmen V, Bacanu F, Drobniene M, Eglitis J, Lakshmaiah KC, Kahan Z, Mardiak J, Pieńkowski T, Semiglazova T, Stamatovic L, Timcheva C, Vasovic S, Vrbanec D, Zaborek P (2014) Delays in diagnosis and treatment of breast cancer : a multinational analysis. Eur J Public Health 24:761–767. https://doi.org/10.1093/eurpub/ckt131
Jung SY, Sereika SM, Linkov F, Brufsky A, Weissfeld JL, Rosenzweig M (2011) The effect of delays in treatment for breast cancer metastasis on survival. Breast Cancer Res Treat 130:953–964. https://doi.org/10.1007/s10549-011-1662-4
Li X, Scarfe A, King K, Fenton D, Butts C, Winget M (2013) Timeliness of cancer care from diagnosis to treatment : a comparison between patients with breast, colon, rectal or Lung cancer. Int J Qual Health Care 25:197–204. https://doi.org/10.1093/intqhc/mzt003
Limam M, Ajmi T, Zedini C, Khelifi A, Mellouli M, El Ghardallou M, Sahli J, Khairi H, Mtiraoui A (2016) Study of Breast Cancer Treatment Waiting Times in Sousse, Tunisia. Santé Publique 28:331–340. https://doi.org/10.3917/spub.163.0331
Maślach D, Krzyżak M, Szpak A, Owoc A, Bielska Lasota M (2013) Waiting time for treatment of women with breast cancer in Podlaskie Voivodeship (Poland) in view of place of residence. A population study. Ann Agric Environ Med 20:161–166
Mayo NE, Scott SC, Shen N, Hanley J, Goldberg MS, MacDonald N (2001) Waiting time for breast cancer surgery in Quebec. CMAJ 164:1133–1138
Meriam K, Manel L, Jihene S, Hédi K, Ali M, Thouraya A (2022) Delays in the Surgical Pathway in Breast cancer Patients in Tunisia : A Descriptive Prospective Study. Indian J Surg Oncol 13:385–393. https://doi.org/10.1007/s13193-021-01484-5
Molinié F, Leux C, Delafosse P, Ayrault Piault S, Arveux P, Woronoff AS, Guizard AV, Velten M, Ganry O, Bara S, Daubisse Marliac L, Tretarre B (2013) Waiting time disparities in breast cancer diagnosis and treatment : A population-based study in France. Breast 22:810–816. https://doi.org/10.1016/j.breast.2013.02.009
Moodley J, Cairncross L, Naiker T, Constant D (2018) From symptom discovery to treatment - Women’s pathways to breast cancer care : a cross-sectional study. BMC Cancer 18:312. https://doi.org/10.1186/s12885-018-4219-7
National Institute for Health and Care Excellence: Clinical Guidelines (2001)
Nessim C, Winocour J, Holloway D P M, Saskin R, Holloway C M B (2015) Wait Times for Breast Cancer Surgery : Effect of Magnetic Resonance Imaging and Preoperative Investigations on the Diagnostic Pathway. JOP 11, e131–e138. https://doi.org/10.1200/JOP.2014.002105
NHS (2020) National Cancer Waiting Times Monitoring Dataset Guidance – Version 11.0
NHS (2022) National Cancer Waiting Times Monitoring Dataset Guidance-version 12.0
NHS ENGLAND (n.d.) Diagnosing cancer earlier and faster
Oudhoff J, Timmermans D, Knol D, Bijnen A, van der Wal G (2007) Waiting for elective general surgery : impact on health related quality of life and psychosocial consequences. BMC Public Health 7:164. https://doi.org/10.1186/1471-2458-7-164
Payne DK, Sullivan MD, Massie MJ (1996) Women’s psychological reactions to breast cancer. Semin Oncol 23:89–97
Plotogea A, Chiarelli AM, Mirea L, Prummel MV, Chong N, Shumak RS, O’Malley FP, Holloway CMB (2013) Factors associated with wait times across the breast cancer treatment pathway in Ontario. Breast Screen Study Group Springer Plus 2:388. https://doi.org/10.1186/2193-1801-2-388
Potter S, Govindarajulu S, Shere M, Braddon F, Curran G, Greenwood R, Sahu AK, Cawthorn SJ (2007) Referral patterns, cancer diagnoses, and waiting times after introduction of two week wait rule for breast cancer : prospective cohort study. BMJ 335:288. https://doi.org/10.1136/bmj.39258.688553.55
Pourcel G, Ledesert B, Bousquet PJ, Ferrari C, Viguier J, Buzyn A (2013) Waiting times for cancer care in four most frequent cancers in several French regions in 2011 and 2012. Bull Cancer 100:1237–1250. https://doi.org/10.1684/bdc.2013.1832
Rapoport Y, Kreitler S, Chaitchik S, Algor R, Weissler K (1993) Psychosocial problems in head-and-neck cancer patients and their change with time since diagnosis. Ann Oncol 4:69–73. https://doi.org/10.1093/oxfordjournals.annonc.a058365
Rastpour A, Begen MA, Louie AV, Zaric GS (2018) Variability of waiting times for the 4 most prevalent cancer types in Ontario : a retrospective population-based analysis. Cmajo 6:E227–E234. https://doi.org/10.9778/cmajo.20170118
Rayson D (2004) Elapsed time from breast cancer detection to first adjuvant therapy in a Canadian province, 1999-2000. Can Med Assoc J 170:957–961. https://doi.org/10.1503/cmaj.1020972
Revaux A, Laas E, Chopier J, Thomassin Naggara I, Touboul E, Antoine M, Gligorov J, Darai E (2014) Delays in treatment of breast cancer: experience of an expert center of the Assistance Publique-Hôpitaux de Paris (AP-HP). Gynecol Obstet Fertil 42:585–590. https://doi.org/10.1016/j.gyobfe.2014.05.005
Richards M, Westcombe A, Love S, Littlejohns P, Ramirez A (1999a) Influence of delay on survival in patients with breast cancer : a systematic review. Lancet 353:1119–1126. https://doi.org/10.1016/S0140-6736(99)02143-1
Richards MA, Smith P, Ramirez AJ, Fentiman IS, Rubens RD (1999b) The influence on survival of delay in the presentation and treatment of symptomatic breast cancer. Br J Cancer 79:858–864. https://doi.org/10.1038/sj.bjc.6690137
Robinson KM, Christensen KB, Ottesen B, Krasnik A (2012) Diagnostic delay, quality of life and patient satisfaction among women diagnosed with endometrial or ovarian cancer : a nationwide Danish study. Qual Life Res 21:1519–1525. https://doi.org/10.1007/s11136-011-0077-3
Shin DW, Cho J, Kim SY, Guallar E, Hwang SS, Cho B, Oh JH, Jung KW, Seo HG, Park JH (2013) Delay to Curative Surgery Greater than 12 Weeks Is Associated with Increased Mortality in Patients with Colorectal and Breast Cancer but Not Lung or Thyroid Cancer. Ann Surg Oncol 20:2468–2476. https://doi.org/10.1245/s10434-013-2957-y
Simunovic M, Thériault ME, Paszat L, Coates A, Whelan T, Holowaty E, Levine M (2005) Using administrative databases to measure waiting times for patients undergoing major cancer surgery in Ontario, 1993-2000. Can J Surg 48:137–142
World Health Organization (2020) Breast cancer : Prevention and Control 2021
Yun YH, Kim YA, Min YH, Park S, Won YJ, Kim DY, Choi IJ, Kim YW, Park SJ, Kim JH, Lee DH, Yoon SJ, Jeong SY, Noh DY, Heo DS (2012) The influence of hospital volume and surgical treatment delay on long-term survival after cancer surgery. Ann Oncol 23:2731–2737. https://doi.org/10.1093/annonc/mds101
Availability of data and materials
The datasets during and/or analyzed during the current study are available from the corresponding author on reasonable request.
Funding
This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Author information
Authors and Affiliations
Contributions
This work was carried out in collaboration between all authors. P. Khairi Hedi and P. Mtiraoui Ali: designed the study, coordinated the study, and manuscript editing. P. Lassoued Latifa: guarantor of the integrity of the study and approval of the final version. P. Ag Bannour Imen and P. Chaieb Anoir: definition of intellectual content, analysis, and interpretation of data. Dr. Sahli Jihene: statistical analysis, analysis, and interpretation of data. Kahlaoui Meriam: literature research, data acquisition, analysis and interpretation, and also wrote the first draft of the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Competing interests
We know of no conflicts of interest associated with this publication, and there has been no significant financial support for this work that could have influenced its outcome.
Ethics approval
This protocol was approved by the ethics committee of Farhat Hached University Hospital. Consent and verbal agreement of the head of the department were obtained. In addition, clear informed oral consent was obtained from the patients. Anonymity and confidentiality of data were guaranteed. Data collection was performed by a single investigator. Data collection was prospective to ensure completeness of data collection and to avoid missing data.
Consent to participate
Not applicable.
Consent for publication
Not applicable.
Certificate of validation
The authors of the article in question attest to the validation of this article, the choice of the journal, and that the work described has not been published before and is not under consideration for publication anywhere else. The corresponding author, Kahlaoui Meriam, confirms that the manuscript has been read and approved for submission by all named authors.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Meriam, K., Latifa, L., Imen, B. et al. Impact of an intervention on waiting times in the surgical pathway of women with breast cancer: a quasi-experimental study. J Public Health (Berl.) (2023). https://doi.org/10.1007/s10389-023-02162-2
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s10389-023-02162-2